Latex Conjugation Kit - 400nm Blue
Be the first to review this product! Submit a review
|
(7 Publications)
- Rapid Conjugation: achieve 400 nm blue latex nanoparticle labeling in under 2 hours with less than 10 minutes of hands-on time.
- Requires less antibody than traditional passive and covalent latex conjugation.
- Latex nanoparticle particles are resistant to aggregation.
- FuncS
Supplier Data
Functional Studies - Latex Conjugation Kit - 400nm Blue (AB269892)
Lateral Flow Assay of our specially treated latex beads conjugated to a monoclonal anti-CRP antibody (mAb1) titrated against CRP. 2ng/mL CRP can easily be detected.
- Flow Cyt
PubMed
Flow Cytometry - Latex Conjugation Kit - 400nm Blue (AB269892)
Latex Conjugation Kit – 400nm Blue.
Rutkowska, Aleksandra, et al used Latex Conjugation Kit – 400nm Blue (ab269892) as part of developing a novel method for rapid and quantitative detection of bisphenol A (BPA) in urine. They used the kit to conjugate Latex to polyclonal anti-Bisphenol A antibodies for use in lateral flow assay.
(A) A scheme of using lateral flow assay for detection of BPA in urine samples. (B) Determination of BPA concentration in urine samples by lateral flow strips and estimation of different levels of individual exposure. (C) Examples of results of the lateral flow assay for differ-ent BPA concentrations in the urine samples, with results validated by LC-MS/MS.
Image from Rutkowska et al., Acta Biochim., 67(3):409-415; doi: 10.18388/abp.2020_5368. Reproduced under the Creative Commons license https://creativecommons.org/licenses/by-sa/4.0/
- FuncS
Supplier Data
Functional Studies - Latex Conjugation Kit - 400nm Blue (AB269892)
Lateral Flow Assay of our specially treated latex conjugated to the monoclonal anti-CRP antibody (mAb2) titrated against CRP in buffer or CRP spiked CRP depleted serum (100 % serum). The latex behaves similarly in serum and buffer, and no aggregation or nonspecific binding is seen.
- LFA
PubMed
Lateral flow assay - Latex Conjugation Kit - 400nm Blue (AB269892)
Kim, Jinsu, et al used Latex Conjugation Kit - 400nm Blue (ab269892) as part of examining human malaria species with multiplex lateral flow immunoassay. They used the kit to conjugate Latex to anti-(pan)pLDH antibodies for use in lateral flow assay.
Representative test strips of the two-colour LFA. Distinct colours were observed at the test lines, corresponding a type of antigens, such as a blue test lines for pLDH detection only, b mixture colour of test lines for simultaneous detection, and c red test lines for PfHRP2 detection only. The mixture colour at control lines indicated the red and blue latex particles migrated along the length of the strip
Image from Kim et al., Malar J., 18(1):313; doi: 10.1186/s12936-019-2957-x. Reproduced under the Creative Commons license https://creativecommons.org/licenses/by/4.0/
- LFA
Unknown
Lateral flow assay - Latex Conjugation Kit - 400nm Blue (AB269892)
Multiplexed Latex.
The three colours of latex each conjugated to a different antibody or protein, forming a line either by a direct binding event (red and black latex) or a sandwich assay binding event (blue latex). The three colours of latex demonstrate no aggregation or background staining.
- LFA
PubMed
Lateral flow assay - Latex Conjugation Kit - 400nm Blue (AB269892)
Bond, Meaghan, et al used Latex Conjugation Kit - 400nm Blue (ab269892) as part of examining rapid tests to identify patients with sickle cell disease. They used the kit to conjugate Latex to anti-HbS and anti-HbA antibodies for use in lateral flow assay.
(a) Representative strips run with varying amounts of normal blood, including a negative control with no blood. Top image shows full-color scan; bottom image shows red channel of the same image. (b) Signal-to-background ratio of strips in part a (normal blood) and the A threshold set by previous experiment. Error bars represent ±1 SD of three strips. *10 μL represents the average of only 2 strips. (c) Representative strips run with varying amounts of sickle cell anemia (SCA) blood, including a negative control with no blood. (d) Signal-to-background ratio of strips in part c (SCA blood) and the S threshold set by previous experiment. A line present at the "A" line indicates normal, at the "S" line indicates SCA, and at neither indicates sickle cell trait (SCT). The positive control line must be present for the test to be valid.
Image from Bond et al., PLoS One, 12(5):e0177732; doi: 10.1371/journal.pone.0177732. Reproduced under the Creative Commons license https://creativecommons.org/licenses/by/4.0/
Product details
Latex Conjugation Kit – 400nm Blue (ab269892) allows antibodies or proteins to be conjugated to our high quality 400 nm latex nanoparticles quickly and easily. The latex nanoparticles are designed for ease of use and have much improved handling compared with traditional latex. This has been achieved by specially treating the nanoparticles. The conjugation is covalent, and requires less antibody than traditional passive and covalent latex conjugation.
The 400 nm blue latex nanoparticles in this kit are freeze dried. The conjugation reaction is initiated simply by reconstituting the dry mixture with the antibody, which becomes attached (via lysine residues) to the specially treated surface.
It takes 30 seconds to set up the conjugation, the hands-on time for the conjugation procedure is about 3 minutes and the conjugate is ready to use within 35 minutes. The biomolecule is simply pipetted into a vial containing the latex nanoparticles, then a centrifugation allows a buffer exchange.
The resulting covalent conjugates can be easily resuspended without the need for harsh methods such as sonication or vortexing, unlike traditional conjugation procedures which are prone to aggregation. This is due to the properties of the surface treatment which makes the particles resistant to aggregation.
Additionally, unlike passive methods, the conjugation procedure has only a weak dependence on the isoelectric point of the antibody. Consequently, extensive trials at different pH values are not required; all antibodies can be conjugated at one of two pHs, both of which are supplied in this kit (Reaction Buffers A and B).
Benefits of Latex Conjugation Kit:
Only 30 seconds to set up the conjugation
Three minutes hands-on time for the conjugation procedure
Conjugate is ready to use within 35 minutes – the biomolecule is simply pipetted into a vial containing the latex nanoparticles, then a centrifugation allows a buffer exchange.
General notes:
This product is manufactured by Expedeon, an Abcam company. It was previously called 400nm Blue Latex Conjugation Kit. Expedeon product code 1000-0040 (4 reaction mini kit) is the same as the 4 x 4 μg size of this product, code 1000-0100 (10 reaction mini kit) is the same as the 10 x 4 μg size, and code 1000-0120 (1 reaction mini kit) is the same as the 1 x 40 μg size of this product.
Buffer requirements:
We would suggest that the antibody to be conjugated should be in 10 – 50 mM MES, HEPES or MOPS at pH 6 – 7 (with no other components e.g. salt or azide) before conjugation. For incompatible buffers and low antibody concentrations, use our rapid antibody purification and concentration kits or Nanoparticles. To learn more about incompatible buffers, please refer to the protocol booklet.
What's included?
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download websiteProtocolBooklet|en
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
The American journal of tropical medicine and hygiene 108:578-580 PubMed36746658
2023
Applications
Unspecified application
Species
Unspecified reactive species
Acta biochimica Polonica 67:409-415 PubMed32730702
2020
Applications
Unspecified application
Species
Unspecified reactive species
Malaria journal 18:313 PubMed31533756
2019
Applications
Unspecified application
Species
Unspecified reactive species
Analytical chemistry 91:5415-5423 PubMed30896928
2019
Applications
Unspecified application
Species
Unspecified reactive species
Preparative biochemistry & biotechnology 48:930-939 PubMed30388960
2018
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 12:e0177732 PubMed28520780
2017
Applications
Unspecified application
Species
Unspecified reactive species
Analytical chemistry 88:8359-63 PubMed27490379
2016
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com